Xenetic Biosciences (XBIO) Invested Capital (2013 - 2016)
Xenetic Biosciences' (XBIO) quarterly Invested Capital came in at $152529.0 in Q3 2016, down 94.58% YoY from $2.8 million in Q4 2015, and little changed on a QoQ basis from $152529.0 in Q2 2016.
Xenetic Biosciences (XBIO) Invested Capital (2013 - 2016) Analysis & Trends
Xenetic Biosciences (XBIO) has 4 years of Invested Capital data on file, last reported at $152529.0 in Q3 2016.
- Quarterly Invested Capital fell 94.58% year-over-year to $152529.0 in Q3 2016, while the trailing twelve-month figure through Jun 2017 was $152529.0 (down 98.53% YoY) and the FY2015 annual result came in at $395000.0, changed 0.0% from the prior year.
- Invested Capital held at $152529.0 in Q3 2016, from $152529.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $7.0 million in Q1 2016 to a low of $152529.0 in Q2 2016.
- A 4-year average of $1.1 million and a median of $395000.0 in 2014 frame the typical range for Invested Capital.
- The widest YoY moves for Invested Capital: up 1672.91% in 2016, down 94.58% in 2016.
- Tracing XBIO's Invested Capital over 4 years: stood at $372813.0 in 2013, then climbed by 5.95% to $395000.0 in 2014, then changed by 0.0% to $395000.0 in 2015, then slumped by 61.39% to $152529.0 in 2016.
- The last three Invested Capital figures came in at $152529.0 (Q3 2016), $152529.0 (Q2 2016), and $7.0 million (Q1 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Xenetic Biosciences | 8.01 Mn | 1.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 152,529.00 |
| Jun 30, 2016 | 152,529.00 |
| Mar 31, 2016 | 7.00 Mn |
| Dec 31, 2015 | 395,000.00 |
| Sep 30, 2015 | 2.81 Mn |
| Jun 30, 2015 | 395,000.00 |
| Mar 31, 2015 | 395,000.00 |
| Dec 31, 2014 | 395,000.00 |
| Sep 30, 2014 | 395,000.00 |
| Jun 30, 2014 | 626,042.00 |
| Mar 31, 2014 | 681,042.00 |
| Nov 30, 2013 | 372,813.00 |
| Aug 31, 2013 | 212,813.00 |